vs

Side-by-side financial comparison of Archrock, Inc. (AROC) and CLOVER HEALTH INVESTMENTS, CORP. (CLOV). Click either name above to swap in a different company.

CLOVER HEALTH INVESTMENTS, CORP. is the larger business by last-quarter revenue ($487.7M vs $377.1M, roughly 1.3× Archrock, Inc.). Archrock, Inc. runs the higher net margin — 31.0% vs -10.1%, a 41.1% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 15.5%). Archrock, Inc. produced more free cash flow last quarter ($126.7M vs $-69.0M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs 18.5%).

Archrock, Inc. is a leading provider of natural gas compression services and equipment solutions for the North American oil and gas sector. Its core offerings include compression system rental, maintenance, aftermarket support, and sales, serving upstream production, midstream transportation and natural gas processing segments.

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

AROC vs CLOV — Head-to-Head

Bigger by revenue
CLOV
CLOV
1.3× larger
CLOV
$487.7M
$377.1M
AROC
Growing faster (revenue YoY)
CLOV
CLOV
+29.2% gap
CLOV
44.7%
15.5%
AROC
Higher net margin
AROC
AROC
41.1% more per $
AROC
31.0%
-10.1%
CLOV
More free cash flow
AROC
AROC
$195.7M more FCF
AROC
$126.7M
$-69.0M
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
18.5%
AROC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AROC
AROC
CLOV
CLOV
Revenue
$377.1M
$487.7M
Net Profit
$116.8M
$-49.3M
Gross Margin
53.0%
Operating Margin
39.4%
-10.1%
Net Margin
31.0%
-10.1%
Revenue YoY
15.5%
44.7%
Net Profit YoY
95.4%
-123.2%
EPS (diluted)
$0.67

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AROC
AROC
CLOV
CLOV
Q4 25
$377.1M
$487.7M
Q3 25
$382.4M
$496.6M
Q2 25
$383.2M
$477.6M
Q1 25
$347.2M
$462.3M
Q4 24
$326.4M
$337.0M
Q3 24
$292.2M
$331.0M
Q2 24
$270.5M
$356.3M
Q1 24
$268.5M
$346.9M
Net Profit
AROC
AROC
CLOV
CLOV
Q4 25
$116.8M
$-49.3M
Q3 25
$71.2M
$-24.4M
Q2 25
$63.4M
$-10.6M
Q1 25
$70.8M
$-1.3M
Q4 24
$59.8M
$-22.1M
Q3 24
$37.5M
$-9.2M
Q2 24
$34.4M
$7.4M
Q1 24
$40.5M
$-19.2M
Gross Margin
AROC
AROC
CLOV
CLOV
Q4 25
53.0%
Q3 25
48.5%
Q2 25
45.4%
Q1 25
47.4%
Q4 24
46.3%
Q3 24
44.4%
24.5%
Q2 24
41.5%
30.3%
Q1 24
42.1%
23.6%
Operating Margin
AROC
AROC
CLOV
CLOV
Q4 25
39.4%
-10.1%
Q3 25
25.3%
-4.9%
Q2 25
22.5%
-2.2%
Q1 25
26.5%
-0.3%
Q4 24
24.0%
-6.4%
Q3 24
18.1%
-2.7%
Q2 24
17.6%
2.0%
Q1 24
20.0%
-6.5%
Net Margin
AROC
AROC
CLOV
CLOV
Q4 25
31.0%
-10.1%
Q3 25
18.6%
-4.9%
Q2 25
16.6%
-2.2%
Q1 25
20.4%
-0.3%
Q4 24
18.3%
-6.6%
Q3 24
12.8%
-2.8%
Q2 24
12.7%
2.1%
Q1 24
15.1%
-5.5%
EPS (diluted)
AROC
AROC
CLOV
CLOV
Q4 25
$0.67
Q3 25
$0.40
Q2 25
$0.36
Q1 25
$0.40
Q4 24
$0.35
Q3 24
$0.22
Q2 24
$0.22
Q1 24
$0.26

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AROC
AROC
CLOV
CLOV
Cash + ST InvestmentsLiquidity on hand
$1.6M
$78.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.5B
$308.7M
Total Assets
$4.3B
$541.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AROC
AROC
CLOV
CLOV
Q4 25
$1.6M
$78.3M
Q3 25
$4.1M
Q2 25
$5.9M
Q1 25
$4.8M
Q4 24
$4.4M
$194.5M
Q3 24
$3.7M
$288.0M
Q2 24
$919.0K
$254.8M
Q1 24
$1.2M
$208.3M
Stockholders' Equity
AROC
AROC
CLOV
CLOV
Q4 25
$1.5B
$308.7M
Q3 25
$1.4B
$340.9M
Q2 25
$1.4B
$344.2M
Q1 25
$1.3B
$336.1M
Q4 24
$1.3B
$341.1M
Q3 24
$1.3B
$342.2M
Q2 24
$894.5M
$324.9M
Q1 24
$882.1M
$292.5M
Total Assets
AROC
AROC
CLOV
CLOV
Q4 25
$4.3B
$541.0M
Q3 25
$4.4B
$559.7M
Q2 25
$4.4B
$575.0M
Q1 25
$4.0B
$583.7M
Q4 24
$3.8B
$580.7M
Q3 24
$3.8B
$653.0M
Q2 24
$2.7B
$674.2M
Q1 24
$2.7B
$671.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AROC
AROC
CLOV
CLOV
Operating Cash FlowLast quarter
$214.5M
$-66.9M
Free Cash FlowOCF − Capex
$126.7M
$-69.0M
FCF MarginFCF / Revenue
33.6%
-14.1%
Capex IntensityCapex / Revenue
23.3%
0.4%
Cash ConversionOCF / Net Profit
1.84×
TTM Free Cash FlowTrailing 4 quarters
$119.6M
$-69.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AROC
AROC
CLOV
CLOV
Q4 25
$214.5M
$-66.9M
Q3 25
$164.5M
$12.1M
Q2 25
$127.5M
$5.4M
Q1 25
$115.6M
$-16.3M
Q4 24
$124.3M
$34.8M
Q3 24
$96.9M
$50.0M
Q2 24
$70.7M
$44.8M
Q1 24
$137.7M
$25.9M
Free Cash Flow
AROC
AROC
CLOV
CLOV
Q4 25
$126.7M
$-69.0M
Q3 25
$29.5M
$11.4M
Q2 25
$16.0M
$4.8M
Q1 25
$-52.5M
$-16.5M
Q4 24
$26.4M
$33.3M
Q3 24
$26.9M
$49.6M
Q2 24
$-20.6M
$44.4M
Q1 24
$37.9M
$25.5M
FCF Margin
AROC
AROC
CLOV
CLOV
Q4 25
33.6%
-14.1%
Q3 25
7.7%
2.3%
Q2 25
4.2%
1.0%
Q1 25
-15.1%
-3.6%
Q4 24
8.1%
9.9%
Q3 24
9.2%
15.0%
Q2 24
-7.6%
12.5%
Q1 24
14.1%
7.3%
Capex Intensity
AROC
AROC
CLOV
CLOV
Q4 25
23.3%
0.4%
Q3 25
35.3%
0.1%
Q2 25
29.1%
0.1%
Q1 25
48.4%
0.0%
Q4 24
30.0%
0.5%
Q3 24
24.0%
0.1%
Q2 24
33.7%
0.1%
Q1 24
37.2%
0.1%
Cash Conversion
AROC
AROC
CLOV
CLOV
Q4 25
1.84×
Q3 25
2.31×
Q2 25
2.01×
Q1 25
1.63×
Q4 24
2.08×
Q3 24
2.58×
Q2 24
2.05×
6.04×
Q1 24
3.40×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AROC
AROC

Horsepower Group Three$112.6M30%
Horsepower Group Two$108.5M29%
Horsepower Group One$105.9M28%
Services$32.9M9%
Over Counter Parts And Component Sales$17.0M5%
Transferred At Point In Time$1.4M0%

CLOV
CLOV

Segment breakdown not available.

Related Comparisons